Fibrobiologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.95

+0.15 (+19.22%)

As of Jun 30, 10:49 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +2,035.7% upside

Low Target $14.74

Average Target $20.24

High Target $23.30

Current Price $0.95

Current
$0.95

Target
$20.24

$14.74 $20.24 avg $23.30

Scenario Analysis

Bear Case

$14.74

1,455.3%

Low target

Base Case

$20.24

+2,035.7%

Avg target

Bull Case

$23.30

+2,358.6%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$15.00

-93.7% from high

52-Week Low

$0.73

+29.6% from low

Target vs 52W High

$20.24

+34.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%